New results from the OMICS study, which will be presented at ASCO, show Universal DX's blood test can detect colorectal cancer with extraordinary accuracy (92% sensitivity/97% specificity), which exceeds currently available non-invasive tests for colorectal cancer screening. Early detection cancer screening via a liquid biopsy is not only critical to save lives, but is a vast market opportunity, ranging between $30B and $75B in the U.S. alone
Read MoreMedical Oncologist, Dr. Nicholas Vogelzang recently presented data on the drug Xofigo at the annual meeting of the American Society of Clinical Oncology.
Read MoreASCO Numatics, the world's leading manufacturer of comprehensive fluid automation, flow control, and pneumatics solutions, has introduced the 212 Series of composite solenoid valves that incorporate the new FasNTM universal connection system.
Read MoreA new white paper, "Five Critical Factors For Selecting Fieldbus Valve Manifolds," from Numatics, Inc., guides original equipment manufacturers (OEMs) and end users in the selection of the best solutions for their given applications.
Read More